{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:08:59Z","timestamp":1790179739861,"version":"4.1.0"},"reference-count":49,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2409405"],"award-info":[{"award-number":["2022YFC2409405"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472015"],"award-info":[{"award-number":["82472015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Hospitals Authority?s Ascent Plan","award":["DFL20241103"],"award-info":[{"award-number":["DFL20241103"]}]},{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W032150102"],"award-info":[{"award-number":["BRWEP2024W032150102"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1021\/acs.molpharmaceut.5c01724","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:23:17Z","timestamp":1775812997000},"page":"2819-2828","source":"Crossref","is-referenced-by-count":1,"title":["Advances in Delta-like Ligand 3-Targeted Diagnosis and Treatment"],"prefix":"10.1021","volume":"23","author":[{"given":"Chunxu","family":"Cao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Nie","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2084-5193","authenticated-orcid":true,"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-7550","authenticated-orcid":true,"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine","place":["Beijing, China"]},{"name":"Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.2217\/ije.14.40"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104524"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-24-0501"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.729765"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac161"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS5100"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav0891"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1278"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000884"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.10.010"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00739-y"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13574"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0611"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0877"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10170"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-025-09854-3"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102812"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5997"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101080"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2312"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6293"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013442"},{"key":"ref23\/cit23","unstructured":"Research, C. for D. E.\n                      FDA Grants Accelerated Approval to Tarlatamab-Dlle for\nExtensive Stage Small Cell Lung Cancer\n                      ; FDA, 2024."},{"key":"ref24\/cit24","unstructured":"Suzhou Zelgen Biopharmaceuticals\nCo.,Ltd.\n                      A Multicenter, Randomized,\nControlled, Open-Label Phase III Study Evaluating the Efficacy and\nSafety of ZG006 for Injection Compared With Investigator-Selected\nChemotherapy in Participants With Relapsed Small Cell Lung Cancer;\nClinical trial registration NCT07189455\n                      ; clinicaltrials.gov, 2025. https:\/\/clinicaltrials.gov\/study\/NCT07189455 (accessed 2025\u201310\u201322)."},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.8104"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01083-5"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.9b00738"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0299"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.1c00121"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263221"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-1433"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1038\/srep09803"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01287"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00249-3"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","unstructured":"Thummalapalli, R.; Tendler, S.; Chou, J. F.; Tarcan, Z. C.; Porfido, C.; Willner, J.; Linkov, I.; Bhanot, U.; Cooper, A. J.; Xu, J.; Harding, J. J.; Rekhtman, N.; Tang, L. H.; Rudin, C. M.; Janjigian, Y. Y.; Sch\u00f6der, H.; Porier, J. T.; Shia, J.; Basturk, O.; Reidy-Lagunes, D.; Capanu, M.; Lewis, J. S.; Bodei, L.; Dunphy, M. P.; Raj, N. Delta-like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.\n                      medRxiv\n                      . 2025 10.1101\/2025.06.24.25330227.","DOI":"10.1101\/2025.06.24.25330227"},{"key":"ref36\/cit36","unstructured":"Hope, T.\n                      Imaging of Solid Tumors Using DLL3 SPECT; Clinical trial registration NCT07052760\n                      ; clinicaltrials.gov, 2025. https:\/\/clinicaltrials.gov\/study\/NCT07052760 (accessed 2025\u201309\u201314)."},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00703"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1533"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203820119"},{"key":"ref40\/cit40","unstructured":"Abdera Therapeutics\u2019 ABD-147 Gets FDA Orphan Drug Status for\nNeuroendocrine Carcinoma\n                      . https:\/\/synapse.patsnap.com\/article\/abdera-therapeutics-abd-147-gets-fda-orphan-drug-status-for-neuroendocrine-carcinoma?utm_source=chatgpt.com (accessed 2025\u201305\u201304)."},{"key":"ref41\/cit41","unstructured":"A phase 1a\/b,\nopen-label, dose-escalation study of\n                        225\n                        Ac-ABD147 for locally\nadvanced or metastatic small cell lung cancer\nand large cell neuroendocrine carcinoma of the lung following platinum-based\nchemotherapy\n                      \n                      . https:\/\/www.abstractsonline.com\/pp8\/#!\/20273\/presentation\/10568 (accessed 2025\u201305\u201304)."},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.1212"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2012.08.004"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0701"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05568-y"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102632"},{"key":"ref47\/cit47","volume-title":"Advancing Nuclear Medicine Through Innovation","author":"National Research Council (US)","year":"2007"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2012.10.002"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21758"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c01724","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c01724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:10:33Z","timestamp":1777882233000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.5c01724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1021\/acs.molpharmaceut.5c01724"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c01724","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}